MELBOURNE, Nov. 12 (Xinhua) — Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying women more likely to respond to an ovarian cancer treatment known as PARP inhibitor therapy.
The…
MELBOURNE, Nov. 12 (Xinhua) — Australian scientists have created a blood test to guide more effective ovarian cancer treatment, by identifying women more likely to respond to an ovarian cancer treatment known as PARP inhibitor therapy.
The…